NSCLC tumors; adjacent normal tissues; LUAD tissues; LUSC tissues
-
not specified
RNA-seq; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RT-qPCR; RNase R Treatment; Clinical Sample Validation; ROC Analysis
ROC curve analysis supports diagnostic potential to discriminate NSCLC from normal tissues (AUC 0.921).
hsa_circ_0077837 is down-regulated in both LUAD and LUSC tumor tissues compared with adjacent normal tissues. It shows strong diagnostic performance for distinguishing NSCLC tumors from normal tissues by ROC analysis.
0.6605
RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
combined biological and clinical study